In a large cohort of T-LGL leukemia patients we showed that the CD8+/CD16+/CD56- LGL phenotype correlates with a specific subset of T-LGL leukemia patients, characterized by STAT3 mutations and neutropenia. This evidence concerns the gene STAT3 and neutropenia.